Highlights [0.03%]
亮点展望
Jia-Horng Kao
Jia-Horng Kao
Comment on "A bibliometric analysis of primary health care publication trends in the Asia-Pacific region from 2011 to 2023" [0.03%]
对“2011年至2023年亚太地区初级卫生保健出版趋势的文献计量分析”的评论
Deng Ting,Liu Ping,Li Jierong et al.
Deng Ting et al.
Controlling nutritional status score as a survival prognosticator in patients with head and neck cancer [0.03%]
营养状况评分在头颈部癌症患者预后预测中的作用
Ming-Hsien Tsai,Chao-Hui Yang,Yao-Te Tsai et al.
Ming-Hsien Tsai et al.
Purpose: This study aimed to evaluate the prognostic significance of the preoperative Controlling Nutritional Status (CONUT) score in head and neck squamous cell carcinoma (HNSCC). ...
Concerns and opportunities in combining TORS and OPR for managing inflammation and oxidative stress in OSA [0.03%]
联合使用TORS和OPR管理OSA患者的炎症和氧化应激的利弊及机会
Yingxue Hu,Qinghui Yang,Pingwei Ni et al.
Yingxue Hu et al.
Comment on "Impact of pre-Omicron COVID-19 vaccine boosters on the risk of Omicron variant infections: A systematic review and meta-regression" [0.03%]
关于“奥密克戎出现前新冠疫苗加强剂对奥密克戎变异株感染风险的影响:系统评价和meta回归”的评论
Venkata Dileep Kumar Veldi,Renu Sah
Venkata Dileep Kumar Veldi
Long-term outcomes of functional endoscopic sinus surgery with selective vidian neurectomy for chronic rhinosinusitis with nasal polyps combined with allergic rhinitis and asthma [0.03%]
内窥镜鼻窦手术联合选择性蝶神经节切断术治疗伴有变应性鼻炎和哮喘型慢性鼻窦炎伴鼻息肉的长期疗效
Chengxun Jin,Yunmeng Wang,Wenjia Wang et al.
Chengxun Jin et al.
Background: Patients with allergic rhinitis (AR), chronic rhinosinusitis (CRS) with nasal polyps (ARwCRSwNP), and asthma often exhibit high recurrence rates after functional endoscopic sinus surgery (FESS), sometimes requ...
Analysis of intracerebral abscesses in Deep Brain Stimulation and association with hardware-related wound complications [0.03%]
脑深部刺激术引起的颅内脓肿与器械相关伤口并发症的关系分析研究
Ozan Hasimoglu,Taha Hanoglu,Tuba Ozge Karacoban et al.
Ozan Hasimoglu et al.
Background: Deep brain stimulation (DBS) is an effective treatment for various neurological disorders, including Parkinson's disease. However, its increasing use has highlighted the risk of serious complications, such as ...
Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan [0.03%]
卡博替尼治疗台湾肾细胞癌患者的真实世界研究
Yu-Chieh Tsai,Jian-Ri Li,Kun-Yuan Chiu et al.
Yu-Chieh Tsai et al.
Background: There is a lack of real-world evidence from Taiwan on the use of cabozantinib for advanced renal cell carcinoma (aRCC). We evaluated cabozantinib treatment for aRCC after previous antiangiogenic therapy in rea...